A carregar...
Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
Treatment of hepatitis C virus (HCV) infection has evolved greatly through the recent decade. The availability of direct-acting antiviral agents (DAAs) targeting the functional proteins of HCV has resulted in the introduction of DAA-based combination therapies, providing an optimal rate of treatment...
Na minha lista:
| Publicado no: | World J Hepatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177567/ https://ncbi.nlm.nih.gov/pubmed/30310532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i9.543 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|